Elevance Health (ELV) and Molina Healthcare (MOH) are prominent players in the managed healthcare sector, providing health insurance and services primarily through government-sponsored programs like Medicaid and Medicare. This comparison is particularly relevant for investors and traders navigating regulatory shifts, such as recent Medicare Advantage rate adjustments, and broader market pressures on medical cost ratios (MCR, the percentage of premiums spent on medical care). With both stocks anticipating Q1 2026 earnings amid sector volatility, understanding their relative performance, risk profiles, and growth drivers can inform portfolio positioning in healthcare stocks.
Elevance Health (ELV) is a diversified health benefits company serving nearly 47 million members across commercial, Medicaid, and Medicare segments. In recent market activity, the stock has exhibited resilience, trading around $319 with a 52-week range of $274 to $433. Shares have gained in recent weeks following dips tied to anticipated Q1 earnings declines and regulatory scrutiny over customer retention. Positive influences include a finalized 2.48% Medicare Advantage payment hike for 2027, bolstering sentiment, alongside consistent analyst buy ratings and price targets averaging $378. Broader pressures from health benefits weakness have tempered gains, but ELV's scale and low beta of 0.49 signal relative stability.
Molina Healthcare (MOH) focuses on government-sponsored health plans, serving about 5.5 million members mainly through Medicaid and Medicare. The stock, trading near $150 within a 52-week range of $121 to $333, has rebounded year-to-date by about 13% after significant earlier declines linked to a Q4 2025 earnings miss and elevated medical costs. Recent weeks show outperformance on select days amid sector recovery, driven by the same Medicare Advantage rate positivity. However, ongoing concerns over declining premiums and higher MCR have weighed on sentiment, with analyst targets clustering around $149 and a beta of 0.55 indicating moderate volatility compared to peers.
Tickeron's Trending AI Robots page curates the top-performing AI trading bots from a library of hundreds that analyze and trade thousands of tickers across stocks, ETFs, and crypto. Only the most suitable for prevailing market conditions earn a spot among the 25 featured trending bots, which employ diverse strategies like swing trading, trend following, and sector-specific plays (e.g., semiconductors, gold miners). Performance stats are compelling: annualized returns range from 30% to over 120%, win rates 55-87%, profit factors 1.5-11.7, and profit-to-drawdown ratios up to 11.4, with average trade durations from minutes to weeks. These bots adapt in real-time using AI/ML, offering virtual or brokerage-linked options. Traders can explore these high-conviction signals tailored to current volatility and trends.
ELV and MOH operate in managed care but differ markedly in scale and focus: ELV's broad portfolio spans commercial and government lines with $199 billion in trailing revenue, versus MOH's niche emphasis on low-income government programs yielding $44 billion. Growth drivers for ELV include membership stability and Carelon services, while MOH relies on Medicaid expansion amid redetermination risks. Recent momentum favors ELV's steadier uptrend over MOH's post-earnings volatility. Risk factors are similar—regulatory changes and MCR pressures—but MOH faces heightened Medicaid exposure. Market sentiment leans toward ELV via stronger analyst conviction and valuation.
Tickeron's AI models would currently favor ELV over MOH, citing superior trend consistency, lower P/E multiples, larger scale for risk mitigation, and higher analyst-implied upside potential. While both benefit from Medicare Advantage tailwinds, ELV's relative stability positions it better amid earnings uncertainty and sector rotation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ELV’s FA Score shows that 1 FA rating(s) are green whileMOH’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ELV’s TA Score shows that 4 TA indicator(s) are bullish while MOH’s TA Score has 4 bullish TA indicator(s).
ELV (@Managed Health Care) experienced а -0.68% price change this week, while MOH (@Managed Health Care) price change was -1.82% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +0.72%. For the same industry, the average monthly price growth was +14.43%, and the average quarterly price growth was +37.57%.
ELV is expected to report earnings on Jul 22, 2026.
MOH is expected to report earnings on Jul 22, 2026.
Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| ELV | MOH | ELV / MOH | |
| Capitalization | 85.8B | 10.2B | 841% |
| EBITDA | N/A | 617M | - |
| Gain YTD | 13.784 | 13.761 | 100% |
| P/E Ratio | 16.73 | 52.93 | 32% |
| Revenue | 200B | 45.1B | 443% |
| Total Cash | N/A | 9.25B | - |
| Total Debt | 31.8B | 3.95B | 806% |
ELV | MOH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 70 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 91 | 100 | |
SMR RATING 1..100 | 98 | 87 | |
PRICE GROWTH RATING 1..100 | 47 | 46 | |
P/E GROWTH RATING 1..100 | 37 | 4 | |
SEASONALITY SCORE 1..100 | 75 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ELV's Valuation (7) in the Managed Health Care industry is significantly better than the same rating for MOH (77). This means that ELV’s stock grew significantly faster than MOH’s over the last 12 months.
ELV's Profit vs Risk Rating (91) in the Managed Health Care industry is in the same range as MOH (100). This means that ELV’s stock grew similarly to MOH’s over the last 12 months.
MOH's SMR Rating (87) in the Managed Health Care industry is in the same range as ELV (98). This means that MOH’s stock grew similarly to ELV’s over the last 12 months.
MOH's Price Growth Rating (46) in the Managed Health Care industry is in the same range as ELV (47). This means that MOH’s stock grew similarly to ELV’s over the last 12 months.
MOH's P/E Growth Rating (4) in the Managed Health Care industry is somewhat better than the same rating for ELV (37). This means that MOH’s stock grew somewhat faster than ELV’s over the last 12 months.
| ELV | MOH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 66% | 2 days ago 58% |
| Stochastic ODDS (%) | 2 days ago 62% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 65% | 2 days ago 63% |
| MACD ODDS (%) | 2 days ago 63% | 2 days ago 61% |
| TrendWeek ODDS (%) | 2 days ago 58% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 56% | 2 days ago 71% |
| Advances ODDS (%) | 16 days ago 56% | 9 days ago 67% |
| Declines ODDS (%) | 6 days ago 56% | 6 days ago 64% |
| BollingerBands ODDS (%) | 2 days ago 67% | 2 days ago 68% |
| Aroon ODDS (%) | 2 days ago 45% | 6 days ago 68% |
A.I.dvisor indicates that over the last year, ELV has been loosely correlated with UNH. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ELV jumps, then UNH could also see price increases.
A.I.dvisor indicates that over the last year, MOH has been loosely correlated with CNC. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if MOH jumps, then CNC could also see price increases.